Poplar Point Capital Partners LP insider trades
Open-market stock purchases and sales by Poplar Point Capital Partners LP, 10% Owner at NovaBay Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 16, 2014.
Track record: 100% of 35 scored buys are up 5% or more since purchase, averaging +220%.
Recent trades
No open-market trades in the last 12 months.
Get free alerts when Poplar Point Capital Partners LP files a new trade →